Supplements and Featured Publications
Abriendo Puertas a los Profesionales con el Multimodal Maestro2
The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions
A Reliable Treatment for Blepharitis/Meibomian Gland Dysfunction, with Increased Ocular Bioavailability
Glaucoma 360: Highlights from 2021
Glaucoma 360: Highlights from 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement
4
Palatin recieves $6.5 million milestone payment from partnership with Boehringer Ingelheim
5
.png "Optometry Times"){kind=logo}
